ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
46 announcements
Mukka Proteins seeks shareholder nod via postal ballot to issue 2 Crore warrants at Rs. 23.50 each, raising Rs. 47 Crore. The funds will support working capital and expansion.
Mukka Proteins will acquire a 51% stake in Aqua Marine for ₹15 Crore. The strategic acquisition aims to expand core business capacity and improve production efficiency.
Mukka Proteins approved acquiring a 51% stake in Delta Marine Products for Rs. 11.10 Crore. This strategic investment expands its core fish meal and oil business.
Mukka Proteins approved a Rs.15 Crore investment for a 51% stake in Aqua Marine, a fish meal and oil manufacturer. This strategic move aims to expand core business capacity and market reach.
Mukka Proteins approved a Rs.47 Crore preferential issue of warrants to non-promoter investors. The funds will support strategic investments and capacity expansion.
Mukka Proteins scheduled a board meeting on June 12, 2026, to consider raising funds via preferential or rights issues. Trading window remains closed for designated persons.
Mukka Proteins Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory adherence despite minor historical observations and penalty payments.
CARE Ratings downgraded Mukka Proteins' bank facilities totaling ₹495 Crore to 'BBB-; Negative'. The downgrade reflects elongated working capital cycles and weakened debt coverage indicators.
Mukka Proteins reported strong FY26 performance with 44% revenue growth reaching ₹1,449.5 Cr. The company is pivoting from a fishmeal producer to an integrated animal protein and sustainability platform.
Mukka Proteins reported strong FY26 performance with revenue growing 44% to ₹1,449.5 Crore. Strategic expansions in Oman and Sri Lanka underscore sustained growth momentum.
Mukka Proteins Ltd reported revenue from operations of ₹380.6 Cr (-0.3% YoY) and net profit of ₹21.4 Cr (+52.9% YoY) for Q4 FY26.
Mukka Proteins scheduled a board meeting for May 15, 2026, to approve audited annual results and debt fundraising. Trading remains closed for designated persons until May 19.
Mukka Proteins scheduled a May 15 board meeting to approve annual results and raise ₹75 Crore via NCDs. The trading window remains closed until May 17.
Mukka Proteins Limited has entered into an inter-corporate loan agreement with its subsidiary, M/s. United Gulf Fishery Products LLC. The loan carries an 8% annual interest rate and a 5-year tenure. The transaction is conducted at arm's length to support the subsidiary's urgent business commitments.
Mukka Proteins Limited has entered into an unsecured loan agreement with its subsidiary, United Gulf Fishery Products LLC, for up to ₹5 Crore. The inter-corporate loan carries an 8% interest rate and a five-year tenure. The funds are intended to meet urgent business commitments of the 68%-owned subsidiary.
Mukka Proteins Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The registrar, Cameo Corporate Services, confirmed no dematerialization requests were received as all company shares are already in demat mode.